PHR · NYSE · Medical - Healthcare Information Services

Phreesia (PHR)

Runs the digital check-in and payment kiosk that replaced the clinic waiting-room clipboard.

$10.10
vs last close+0.06 (+0.65%)
Loading prices…

Phreesia, Inc.PHR
Health Care

Builds and sells a subscription software platform that manages patient check-in, scheduling and payments for healthcare providers, while a second business line sells life sciences companies access to patients through the same check-in flow. Operates as an all-remote company with staff spread across the United States rather than a central office.

Founded in 2005, the company replaced the paper clipboard in doctors' waiting rooms with a self-service check-in kiosk, then grew into a software platform covering patient intake, scheduling and payments for healthcare provider organizations.

Providers pay subscription and processing fees for registration, insurance checks and copay collection; life sciences companies pay to reach patients with targeted outreach delivered through the same check-in flow, a channel reported as Network Solutions. Growth since has come through acquisition — scheduling, specialist search, hospital e-forms and, in 2025, healthcare payment financing.

The company operates without a physical office, with staff distributed across the United States and only a mailing address in Delaware on file. A 2024 breach at an acquired after-hours communication service and an active securities class action over Network Solutions growth claims are the two open matters shaping its current legal exposure.

Company facts

CEOChaim Indig
ListedJul 18, 2019
ExchangeNYSE
HeadquartersWilmington, DE
CountryUnited States
Employees1,789
CIK0001412408
ISINUS71944F1066

Market cap$620.0M
EPS (ttm)$0.1690
P/E (ttm)59.35
ROE3.0%
P/B1.67
P/S1.22
Dividend yieldDiv yield
Beta0.35vs XLV 0.34

Price target$12.00+19.6%Average of 26 analysts
ConsensusBuy18 of 26 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Sep 8, 2026Raymond JamesDowngrade
Rating: Outperform
Rating: Market Perform
Sep 4, 2026DA DavidsonReiterate
Rating: Target: $14
Rating: BuyTarget: $13
Sep 4, 2026Robert W. BairdTarget
Target: $25
Target: $11
Sep 3, 2026Wells FargoReiterate
Rating: Target: $9
Rating: Equal WeightTarget: $10
May 28, 2026Piper SandlerTarget
Target: $30
Target: $12

Next report
Dec 14, 26
in 83 days
EPS estimate
$0.13
Revenue estimate
$128.3M
Fiscal quarter
Q3 FY27

EPSReportedEstimate

Mar '25May '25Sep '25Dec '25Mar '26May '26Sep '26Dec '26
Reported−$0.11−$0.07$0.01$0.10$0.02$0.05$0.03Pending
Estimate−$0.19−$0.13−$0.07$0.00$0.07$0.02$0.09$0.13
Surprise+42.1%+46.2%+114.3%−67.4%+150.0%−64.7%

RevenueReportedEstimate

Mar '25May '25Sep '25Dec '25Mar '26May '26Sep '26Dec '26
Reported$109.7M$115.9M$117.3M$120.3M$127.1M$130.9M$129.5MPending
Estimate$108.9M$114.9M$116.5M$120.0M$126.8M$130.1M$129.1M$128.3M
Surprise+0.7%+0.9%+0.6%+0.3%+0.2%+0.7%+0.3%
Estimate$0.13
ReportedDue Dec 14, 2026
Estimate$128.3M
ReportedDue Dec 14, 2026
View details

Debt to equity18.30%
Current ratio176.20%

ProfitabilityRevenueNet incomeNet margin

Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue$106.8M$109.7M$115.9M$117.3M$120.3M$127.1M$130.9M$129.5M
Net income−$14.4M−$6.4M−$3.9M$654.0K$4.3M$1.3M$3.0M$1.9M
Net margin0.0%0.0%0.0%0.6%3.5%1.0%2.3%1.5%

GrowthOperating income

Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Operating income−$13.8M−$7.6M−$3.3M−$1.5M$3.7M−$5.6M$7.0M$11.1M
YoY growthLoss narrowedLoss narrowedLoss narrowedLoss narrowedTurned profitLoss narrowedTurned profitTurned profit

Balance sheet, Jul 31, 2026Cash & short-term investments $72.9M · Total debt $67.9M · Total assets $647.0M · Shareholders' equity $371.9M

Revenue
$129.5M
Operating income
$11.1M
Net income
$1.9M
View details

No dividends on record.

Institutions94.76%58.82M shares
237 holders · as of Jun 30, 2026
Insiders6.20%3.85M shares
14 holders · as of Sep 16, 2026
Strategic holders19.32%11.99M shares
2 holders · as of Apr 2, 2026
Adds to120.28%

62.07M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

These groups come from separate filings that can overlap, so they add to 120.28%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Pale Fire Capital SEInstitution
14.38%8.92Mas of Jun 30, 2026
Pale Fire Capital SICAV a.s.Strategic
14.38%8.92Mfiled Apr 2, 2026
T. Rowe Price Associates, Inc.Institution
12.56%7.80Mfiled Feb 14, 2022
BlackRock, Inc.Institution
11.31%7.02Mas of Jun 30, 2026
AQR Capital Management LLCInstitution
5.08%3.15Mas of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Jul 16, 2026Yvonne Huiofficer: Principal Accounting Officer−1,247$10.92
Jul 14, 2026Lisa Egbuonu-Davisdirector−536$10.70
Jul 6, 2026Yvonne Huiofficer: Principal Accounting Officer−1,371$10.84
Jun 25, 2026Lisa Egbuonu-Davisdirector−2,546$9.53
May 18, 2026Yvonne Huiofficer: Principal Accounting Officer−431$8.85
View details

  • OptimizeRx

    Direct contest for point-of-care pharma marketing to patients and HCPs

  • Waystar

    Head-to-head on patient payments and revenue-cycle across health systems

  • Weave Communications

    Contests front-office intake, comms and payments for SMB practices

  • Doximity

    HCP-side pharma marketing draws the same life-sciences budgets

  • EverCommerce

    EverHealth's DrChrono and Updox contest EHR-adjacent intake and comms

Compare

CompanyPriceChange
Phreesia$10.10+0.65%$620.0M59.317.31.2+10.4%
OptimizeRx$7.59+0.40%$141.9M32.48.41.4−29.8%
Waystar$25.55−0.64%$4.93B36.714.74.1+18.1%
Weave Communications$7.35+0.34%$582.4M37.72.3+15.5%
Doximity$26.67−0.63%$5.02B31.619.17.7+7.3%
EverCommerce$7.98−3.27%$1.46B44.910.92.4+2.7%
Median34.514.72.4+7.3%